Identification of an epigenetically and phenotypically distinct peritumoral glioblastoma cell population linked to inferior patient outcome
Authors:
Preprint
Abstract
Glioblastoma (GB) is an aggressive and therapy-resistant primary brain tumor with dismal prognosis. Lethality is in most patients caused by a local peritumoral (Edge) relapse near the resection cavity. This region is insufficiently studied and experimental models are scarce. We have analyzed matched tissue samples and cell cultures from bulk tumors and Edge regions of 11 GB patients. Genomic profiling displayed similar genetic alterations and subclonal distributions of matched bulk and Edge regions. Functional, phenotypic and combined single nucleus (sn) RNA-seq and ATAC-seq analyses showed distinct differences between bulk and Edge GB cells with similar shifts across patients. Sn multiomics uncovered a subset of Edge cells defined by unique chromatin accessibility signatures and elevated mesenchymal and immune gene expression. Integrated computational and functional investigations converged on microglia-derived Oncostatin-M as a driver of the Edge-unique phenotype, and high expression of Edge-related signatures correlated with inferior patient outcome in independent GB cohorts.Keywords
Funding Information
- Swedish Research Council (2022-01114)
- Swedish Research Council (2022-00969)
- Swedish Research Council (2022-00658)
- Swedish Research Council (2024-03756)
- Sjöbergstiftelsen (2020-162)
- Knut and Alice Wallenberg Foundation (KAW 2023.0046)
This publication has 82 references indexed in Scilit:
- Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastomaCancer Cell, 2021
- FOXO transcription factor family in cancer and metastasisCancer and Metastasis Reviews, 2020
- Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the MicroenvironmentCancer Cell, 2017
- Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for GlioblastomaJAMA, 2015
- Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like CellsCell, 2014
- 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastomaActa Neurochirurgica, 2013
- The Somatic Genomic Landscape of GlioblastomaCell, 2013
- Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastomaJournal of Neuro-Oncology, 2012
- Radiographic patterns of relapse in glioblastomaJournal of Neuro-Oncology, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010